Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-26 5:29 pm Purchase |
2025-03-24 | 13G | Lomond Therapeutics Holdings, Inc. | Qatar Investment Authority | 2,500,000 7.760% |
2,500,000 (New Position) |
Filing History |
| 2025-02-14 4:01 pm Purchase |
2024-12-31 | 13G | Lomond Therapeutics Holdings, Inc. | Ian Jacobs | 175,000 0.590% |
175,000 (New Position) |
Filing History |
| 2025-02-14 4:00 pm Purchase |
2024-12-31 | 13G | Lomond Therapeutics Holdings, Inc. | Mark N. Tompkins | 1,187,500 4.000% |
1,187,500 (New Position) |
Filing History |
| 2025-01-31 4:07 pm Purchase |
2025-01-24 | 13G | Lomond Therapeutics Holdings, Inc. | Yosemite Fund I, L.P. | 2,500,000 8.400% |
2,500,000 (New Position) |
Filing History |
| 2024-11-08 7:55 pm Purchase |
2024-11-01 | 13D | Lomond Therapeutics Holdings, Inc. | TPAV LLC | 2,729,672 10.000% |
2,729,672 (New Position) |
Filing History |
| 2024-11-08 7:54 pm Purchase |
2024-11-01 | 13D | Lomond Therapeutics Holdings, Inc. | Eilean Therapeutics LLC | 14,420,383 53.000% |
14,420,383 (New Position) |
Filing History |
| 2024-11-08 7:15 pm Purchase |
2024-11-01 | 13D | Lomond Therapeutics Holdings, Inc. | ORBIMED ADVISORS LLC | 2,677,256 9.800% |
2,677,256 (New Position) |
Filing History |
| 2024-11-08 5:00 pm Purchase |
2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | BERDING JOHN B | 1,722,222 6.330% |
1,722,222 (New Position) |
Filing History |
| 2024-11-08 5:00 pm Purchase |
2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | LINDNER S CRAIG | 1,722,222 6.330% |
1,722,222 (New Position) |
Filing History |
| 2024-11-08 5:00 pm Purchase |
2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | AMERICAN FINANCIAL GROUP INC AFG |
1,722,222 6.330% |
1,722,222 (New Position) |
Filing History |
| 2024-11-08 4:49 pm Purchase |
2024-11-01 | 13G | Lomond Therapeutics Holdings, Inc. | Flynn James E | 2,692,625 9.900% |
2,692,625 (New Position) |
Filing History |
| 2023-02-13 5:22 pm Purchase |
2022-12-31 | 13G | Lomond Therapeutics Holdings, Inc. | Ian Jacobs | 250,000 5.000% |
250,000 (New Position) |
Filing |
| 2023-02-10 2:14 pm Purchase |
2022-12-31 | 13G | Lomond Therapeutics Holdings, Inc. | Mark N. Tompkins | 4,750,000 95.000% |
4,750,000 (New Position) |
Filing |